drugset / Trial / NCT03222622
Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
Phase 2
Terminated
136 enrolled
Betta Pharmaceuticals Co., Ltd.
Tigermed Consulting Co., Ltd · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a phase II study to evaluate the efficacy and safety of Icotinib Hydrochloride Cream in patients with mild to moderate psoriasis.
Timeline
- Start
- 2017-11-29
- Primary completion
- 2018-08-15
- Completion
- 2018-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icotinib | Small molecule | 1 % | Topical |
| Subject | Icotinib | Small molecule | 2 % | Topical |
| Subject | Icotinib | Small molecule | 4 % | Topical |